Twist Bioscience (TWST) Other Non-Current Assets (2018 - 2026)

Twist Bioscience (TWST) has reported Other Non-Current Assets for 9 consecutive years, with $5.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Other Non-Current Assets rose 38.52% year-over-year to $5.4 million in Q2 2026; TTM through Jun 2026 was $5.4 million, a 38.52% increase from a year earlier, with the FY2025 full-year figure at $4.9 million, up 74.08% from the prior year.
• Other Non-Current Assets was $5.4 million for Q2 2026 at Twist Bioscience, down from $5.4 million in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $6.9 million in Q1 2022 and troughed at $2.4 million in Q1 2023.
• A 5-year average of $4.5 million and a median of $4.8 million in 2025 frame the typical range for Other Non-Current Assets.
• Across the five-year window, Other Non-Current Assets tumbled 65.73% in 2023 and jumped 128.12% in 2024, its largest moves.
• Over 5 years, Other Non-Current Assets stood at $2.9 million in 2022, then jumped by 85.42% to $5.4 million in 2023, then plunged by 36.42% to $3.4 million in 2024, then surged by 37.3% to $4.7 million in 2025, then rose by 13.66% to $5.4 million in 2026.
• The last three Other Non-Current Assets figures came in at $5.4 million (Q2 2026), $5.4 million (Q1 2026), and $4.7 million (Q4 2025), per Business Quant data.